22nd Century Group (XXII) Says Phase III Study using its SPECTRUM Research Cigarettes Shows Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm
Tweet Send to a Friend
22nd Century Group, Inc. (NYSE: XXII), a plant biotechnology company that is focused on tobacco harm reduction, announced today that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
